The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic riskAntoine Andorin, Vincent Probst, Dominique Babuty et al.|Heart Rhythm|2017Cited by 75
Targeted resequencing identifies TRPM4 as a major gene predisposing to progressive familial heart block type IXavier Daumy, Jean‐Jacques Schott, Mohamed‐Yassine Amarouch et al.|International Journal of Cardiology|2016Cited by 62
Progressive Atrial Conduction Defects Associated With Bone Malformation Caused by a Connexin-45 MutationAkiko Seki, Naomasa Makita, Taisuke Ishikawa et al.|Journal of the American College of Cardiology|2017Cited by 39
Parental Electrocardiographic Screening Identifies a High Degree of Inheritance for Congenital and Childhood Nonimmune Isolated Atrioventricular BlockAlban‐Elouen Baruteau, Vincent Probst, Albin Behaghel et al.|Circulation|2012Cited by 30
Identification of a strong genetic background for progressive cardiac conduction defect by epidemiological approachJean‐Baptiste Gourraud, Vincent Probst, Florence Kyndt et al.|Heart|2012Cited by 15